# Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

> **NCT07445984** · NA · RECRUITING · sponsor: **Azienda Ospedaliero-Universitaria di Parma** · enrollment: 250 (estimated)

## Conditions studied

- Chronic Leukemia
- Acute Leukemia
- Myeloproliferative Disorders
- Lymphoproliferative Disorders
- Myelodysplastic Disorders

## Interventions

- **OTHER:** Genetic, molecular and/or omics analyses

## Key facts

- **NCT ID:** NCT07445984
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Parma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-28
- **Primary completion:** 2026-07-28
- **Final completion:** 2026-07-28
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07445984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07445984, "Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07445984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*